BioSpace News Archive

The global automated cell counter market size was valued at USD 6.48 billion in 2023 and it is projected to surpass around USD 11.20 billion by 2033 with a CAGR of 5.62% from 2024 to 2033.

Biolexis Therapeutics, Inc. today announced it will present five posters at the 2024 American Association for Cancer Research (AACR), taking place April 5-10, 2024, in San Diego, CA.

Sciton Inc., the leading manufacturer of medical and aesthetic lasers and light source technologies, will kick-off their new event series, Skin CEO with the inaugural event taking place this weekend in Austin, TX.

BioSyent Inc. announces that Mr. René Goehrum, President and CEO of BioSyent, will be presenting in person at the LD Micro Invitational XIV Conference in New York City on Tuesday, April 9th at 8:00am EDT.

NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2023 and provided a business update.

Novavax, Inc. will showcase continued progress on data from its updated COVID-19 vaccine (NVX-CoV2601) and provide an overview of its influenza and COVID-19-Influenza Combination (CIC) vaccine candidates at the World Vaccine Congress 2024 (WVC) in Washington, DC, April 2 to 4, 2024.

Lunit today announced the presentation of seven studies at the American Association for Cancer Research (AACR) 2024 Annual Meeting in San Diego, California, from April 5 to 10.

C₂N Diagnostics’ PrecivityAD blood test, used by healthcare providers to determine Alzheimer’s disease (AD) pathology, has the potential to provide significant cost savings, according to a new study published in Population Health Management.

Alpine Immune Sciences, Inc. (NASDAQ: ALPN) has announced that the Company will present updated clinical data for povetacicept from RUBY-3, a phase 1b/2a study of povetacicept in autoimmune glomerulonephritis, including IgA nephropathy, in a late breaking poster presentation at the World Congress of Nephrology April 13-16, 2024 in Buenos Aires, Argentina.

Gain Therapeutics, Inc. today announces the appointment of Jonas Hannestad, M.D., Ph.D. as its chief medical officer, effective as of March 25, 2024.